Get started
Author

Rosa Argüeso

Observed names: Argüeso Armesto, Rosa, R Argueso, R Argüeso, R. Argüeso, Rosa Argueso, Rosa Argüeso Armesto, Rosa Argüeso-Armesto, Rosa M. Argüeso, Rosa María Argüeso-Armesto
Observed institutions: Universidad Complutense de Madrid, Hospital Clínico San Carlos, Clínica Las Condes, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Hospital Universitario Lucus Augusti, Servicio Gallego de Salud, Hospital Xeral Calde, Servicio Extremeño de Salud
ORCID: 0000-0003-0758-0848
Observed ORCID: 0000-0003-0758-0848
OpenAlex ID: A5106264568
Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)
2017 · Leopoldo Pérez de Isla, Rodrigo Alonso, et al. · Circulation · 356
PDF
Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia
2016 · Leopoldo Perez de Isla, Rodrigo Alonso, et al. · Journal of the American College of Cardiology · 252
PDF
Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study
2023 · Leopoldo Pérez de Isla, Jose L. Díaz-Díaz, et al. · Circulation · 96
PDF
Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain
2008 · F Palos-Paz, O Perez-Guerra, et al. · European Journal of Endocrinology · 70
Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study
2018 · Leopoldo Pérez de Isla, Rodrigo Alonso, et al. · Journal of clinical lipidology · 62
Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry
2016 · Rodrigo Alonso, Jose Luis Díaz-Díaz, et al. · Journal of clinical lipidology · 58
PDF
Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study
2019 · Leopoldo Pérez de Isla, Raquel Arroyo-Olivares, et al. · Journal of clinical lipidology · 33
Persistence with long-term PCSK9 inhibitor treatment and its effectiveness in familial hypercholesterolaemia: data from the SAFEHEART study
2022 · Rodrigo Alonso, Raquel Arroyo-Olivares, et al. · European Journal of Preventive Cardiology · 28
PDF
Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience
2021 · Rodrigo Alonso, Ovidio Muñiz-Grijalvo, et al. · Journal of clinical lipidology · 20
Hiperlipidemia familiar combinada: documento de consenso
2014 · Pedro Mata, Rodrigo Alonso, et al. · Atención Primaria · 20
Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study
2024 · Leopoldo Pérez de Isla, Jose L. Díaz-Díaz, et al. · Circulation Cardiovascular Imaging · 19
Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime?
2022 · Rodrigo Alonso, Rosa Argüeso, et al. · Current Atherosclerosis Reports · 19
MRI of Mediastinal Parathyroid Cystic Adenoma Causing Hyperparathyroidism
1996 · R. Soler, A. Bargiela, et al. · Journal of Computer Assisted Tomography · 17
Improved lipid-lowering treatment and reduction in cardiovascular disease burden in homozygous familial hypercholesterolemia: The SAFEHEART follow-up study
2024 · Rodrigo Alonso, Raquel Arroyo-Olivares, et al. · Atherosclerosis · 13
PDF
Incidencia de eventos cardiovasculares y cambios en el riesgo estimado y en el tratamiento de la hipercolesterolemia familiar: registro SAFEHEART
2020 · Leopoldo Pérez de Isla, Raquel Arroyo-Olivares, et al. · Revista Española de Cardiología · 12
Hiperlipidemia familiar combinada: documento de consenso
2014 · Pedro Mata, Rodrigo Alonso, et al. · Medicina de Familia SEMERGEN · 6
Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients
2022 · Leopoldo Pérez de Isla, Rodrigo Alonso, et al. · Journal of clinical lipidology · 5
Rationale, design and preliminary results of the GALIPEMIAS study (prevalence and lipid control of familial dyslipidemia in Galicia, northwest Spain)
2018 · Rosa María Argüeso-Armesto, Teresa-Rosalia Pérez-Castro, et al. · International Journal of Clinical Practice · 4
PDF
Observance of the Atlantic Diet in a Healthy Population from Galicia (NW Spain): A Comparative Study Using a New Scale-Based Procedure to Assess Adherence
2025 · Inés Rivas-Fernández, Paula Roade-Pérez, et al. · Foods · 2
PDF
Prevalencia de dislipemia aterogénica, factores relacionados y grado de control lipídico en la población general de Galicia. Estudio GALIPEMIAS
2023 · Carlos Názara, Rosa M. Argüeso, et al. · Clínica e Investigación en Arteriosclerosis · 2
Persistence to long-term PCSK9 inhibitors treatment and its effectiveness in familial hypercholesterolemia: data from the SAFEHEART study
2022 · R Alonso, R Arroyo-Olivares, et al. · European Heart Journal · 1
Prevalence of familial dyslipidemias, degree of lipid control and relationship with atherosclerotic cardiovascular disease in the general population of Galicia. GALIPEMIAS Study
2025 · José Luis Díaz-Díaz, M. Eugenia Ameneiros, et al. · Clínica e Investigación en Arteriosclerosis (English Edition)
Alirocumab reduces total coronary plaque burden in patients with familial hypercholesterolaemia and no previous clinical atherosclerotic disease
2022 · L Perez De Isla, J L Diaz Diaz, et al. · European Heart Journal
PDF
Complicaciones postoperatorias de by-pass laparoscópico, “primum non nocere”
2015 · María Isabel Pérez Moreiras, Rocío González López, et al.
[Central diabetes insipidus secondary to infundibuloneurohypophysitis].
1998 · M L Isidro, A Martínez, et al. · PubMed
Works count: 27
Citation count: 1,095
H-index: 13
I10-index: 15
Year
Topic
Type